Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat Dose-Ranging in Hemodialysis Anemia
NCT01977482Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 2 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by GSK. Started Nov 2013; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01977482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977482.